0000950170-24-016462.txt : 20240216
0000950170-24-016462.hdr.sgml : 20240216
20240216164302
ACCESSION NUMBER: 0000950170-24-016462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOOD JENNIFER L
CENTRAL INDEX KEY: 0001229245
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 24649058
MAIL ADDRESS:
STREET 1: 15 GREAT RING ROAD
CITY: SANDY HOOK
STATE: CT
ZIP: 06482
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
ownership.xml
4
X0508
4
2024-02-15
0001563880
Trevi Therapeutics, Inc.
TRVI
0001229245
GOOD JENNIFER L
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 16TH FLOOR
NEW HAVEN
CT
06510
true
true
false
false
President & CEO
false
Stock Option (right to buy)
2.38
2024-02-15
4
A
false
630000
0.00
A
2034-02-14
Common Stock
630000
630000
D
This option was granted on February 15, 2024. The 630,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028.
/s/ Christopher Galletta, attorney-in-fact
2024-02-16